PAIGE LOMBARD: Open Payments
NPI 1770005829 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,079 in 93 payments from 21 companies in 2025. Trend: 2023 $1,404 · 2024 $1,653 · 2025 $2,079
Food & beverage: $2,045Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $447 |
| GlaxoSmithKline, LLC. | 26 | $299 |
| GENZYME CORPORATION | 7 | $248 |
| Galderma Laboratories, L.P. | 4 | $170 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| Grifols USA, LLC | 1 | $103 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Amgen Inc. | 4 | $92 |
| PFIZER INC. | 4 | $78 |
| Electromed, Inc. | 4 | $72 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, NEMLUVIO, TRELEGY ELLIPTA, NUCALA, Xembify, TEZSPIRE.
Industry payments across IN — which companies pay providers there.
